Company: INDP
Filing Date: 2025-06-26
Form Type: 8-K
Source: 0001641172-25-016694
Chunk: 0

Company: Indaptus Therapeutics, Inc.
Filing Date: 2025-06-26
Form: 8-K
Item: Item 5.03
Chunk 0
---
Item       Amendment                                                       

As
previously reported in its Current Report on Form 8-K filed with the Securities and Exchange Commission (the “ SEC”) on
June 11, 2025, Indaptus Therapeutics, Inc. (the “ Company”) held its annual meeting of stockholders on June 10, 2025
(the “ Annual Meeting”). At the Annual Meeting, the stockholders approved, among other things, a proposal to approve an
amendment to the Company’s Amended and Restated Certificate of Incorporation, as amended, in the form set forth on Appendix
A

The Board approved a 1-for-28 reverse stock split of the Company’s issued and outstanding shares of common stock, par value $0.01 per
share, (the “ Reverse Stock Split”), and on June 26, 2025, the Company filed with the Secretary of State of the State of Delaware
a Certificate of Amendment to its Amended and Restated Certificate of Incorporation (the “ Certificate of Amendment”) to effect
the Reverse Stock Split, which became effective as of 5:00 p. m. Eastern Time on June 26, 2025. The Company’s common stock will
begin trading on a split-adjusted basis when the market opens on June 27, 2025 on the Nasdaq Capital Market.